Ciitizen (@ciitizen) 's Twitter Profile
Ciitizen

@ciitizen

ID: 938520239918137344

linkhttp://www.ciitizen.com calendar_today06-12-2017 21:27:16

1,1K Tweet

1,1K Followers

410 Following

Ciitizen (@ciitizen) 's Twitter Profile Photo

Time is running out, don’t forget to register for our latest webinar, July 12th at 4:30pm PT. Learn about the benefits of Invitae’s Ciitizen and the neuro research opportunities available. Register: bit.ly/3bUzxCD

Time is running out, don’t forget to register for our latest webinar, July 12th at 4:30pm PT. Learn about the benefits of Invitae’s Ciitizen and the neuro research opportunities available. Register: bit.ly/3bUzxCD
Ciitizen (@ciitizen) 's Twitter Profile Photo

We're working with the Cholangiocarcinoma Foundation to improve the lives of #cholangiocarcinoma patients by accelerating research. Join us today. bit.ly/3MRvpjH Cholangiocarcinoma Foundation

We're working with the Cholangiocarcinoma Foundation to improve the lives of #cholangiocarcinoma patients by accelerating research. Join us today. bit.ly/3MRvpjH <a href="/curecc/">Cholangiocarcinoma Foundation</a>
Ciitizen (@ciitizen) 's Twitter Profile Photo

Our PCDH19-Related Epilepsy Digital Natural History Study is now recruiting patients. Learn how to participate in this important research here: bit.ly/3uHveAh

Ciitizen (@ciitizen) 's Twitter Profile Photo

We are excited to join FamilieSCN2A at the #SCN2A Summer Seminar in-person this year, July 28-29th! Learn more about our SCN2A research study available now bit.ly/3J2fPl3 #epilepsy #geneticepilepsy #genetictesting

We are excited to join <a href="/FamilieSCN2A/">FamilieSCN2A</a> at the #SCN2A Summer Seminar in-person this year, July 28-29th! Learn more about our SCN2A research study available now bit.ly/3J2fPl3

#epilepsy #geneticepilepsy #genetictesting
Ciitizen (@ciitizen) 's Twitter Profile Photo

We believe in patient-first research to improve future outcomes. Explore our current research opportunities and join us today to experience the free, secure benefits of Invitae’s Ciitizen. bit.ly/3NL86ZB

We believe in patient-first research to improve future outcomes. Explore our current research opportunities and join us today to experience the free, secure benefits of Invitae’s Ciitizen. bit.ly/3NL86ZB
Ciitizen (@ciitizen) 's Twitter Profile Photo

We're proud to partner with the Cholangiocarcinoma Foundation to help patients control their health data. Join this important research today: bit.ly/3IoumH8 Cholangiocarcinoma Foundation

We're proud to partner with the Cholangiocarcinoma Foundation to help patients control their health data. Join this important research today: bit.ly/3IoumH8 <a href="/curecc/">Cholangiocarcinoma Foundation</a>
Invitae (@invitae) 's Twitter Profile Photo

@Ciitizen by Invitae is a 100% free service for patients to get more out of their health records. Our platform enables patients to find potentially better treatment options and allows the opportunity to advance the research for cures. Learn more: ciitizen.com/join-us/

@Ciitizen by Invitae is a 100% free service for patients to get more out of their health records. Our platform enables patients to find potentially better treatment options and allows the opportunity to advance the research for cures. Learn more: ciitizen.com/join-us/
SynGAP Research Fund (SRF) (@curesyngap1) 's Twitter Profile Photo

News! Praxis Medicines, who's developing an #ASO for #SYNGAP1 (#S10e58 @ Syngap.Fund/E58) is launching a study in partnership with #SRF & Ciitizen/Invitae. Join us THIS Thurs to learn more. Register @ Syngap.Fund/Tracker. Ciitizen registry: Ciitizen.com/Syngap1

News! <a href="/PraxisMedicines/">Praxis Medicines</a>, who's developing an #ASO for #SYNGAP1 (#S10e58 @ Syngap.Fund/E58) is launching a study in partnership with #SRF &amp; <a href="/ciitizen/">Ciitizen</a>/<a href="/Invitae/">Invitae</a>. Join us THIS Thurs to learn more.  Register @ Syngap.Fund/Tracker. Ciitizen registry: Ciitizen.com/Syngap1
Sydney Stelmaszek (@sydneystel) 's Twitter Profile Photo

“We were literally handed the raw data immediately”Praxis Medicines on sourcing SynGAP Research Fund (SRF) data on Ciitizen and Invitae! 💃🏻Also, still the handsomest little fella on that front page 😍 Thanks Mike Graglia 🌻, Virginie McNamar, and team for making us a highly recruitable bunch!

“We were literally handed the raw data immediately”<a href="/PraxisMedicines/">Praxis Medicines</a> on sourcing <a href="/cureSYNGAP1/">SynGAP Research Fund (SRF)</a> data on <a href="/ciitizen/">Ciitizen</a> and <a href="/Invitae/">Invitae</a>! 💃🏻Also, still the handsomest little fella on that front page 😍 Thanks <a href="/JMGraglia/">Mike Graglia 🌻</a>, <a href="/McNamarVirginie/">Virginie McNamar</a>, and team for making us a highly recruitable bunch!
Praxis Medicines (@praxismedicines) 's Twitter Profile Photo

SynGAP Research Fund (SRF) Ciitizen Invitae As a team built of #rare parents, we’re proud to sponsor this initiative. We're grateful to your organization & the #SYNGAP1 community who are proactively gathering and sharing invaluable insights and using tools like @Ciitizen/Invitae to help us move innovation forward quickly.

SynGAP Research Fund (SRF) (@curesyngap1) 's Twitter Profile Photo

👋 Friendly Reminder: #SYNGAP Seizure Tracker Study This is happening! Sign up for Ciitizen at Ciitizen.com/Syngap1 Log in at: app.Ciitizen.com Ciitizen @invitae #Studies #careaboutrare #rarediseaseresearch #syngap1

👋 Friendly Reminder: #SYNGAP Seizure Tracker Study

This is happening! 
Sign up for Ciitizen at Ciitizen.com/Syngap1
Log in at: app.Ciitizen.com

<a href="/ciitizen/">Ciitizen</a> @invitae 
#Studies #careaboutrare #rarediseaseresearch #syngap1
Invitae (@invitae) 's Twitter Profile Photo

Want to have your comprehensive medical history under your control and at your fingertips? Then join Invitae’s Ciitizen: ciitizen.com/join-us #MedicalData #Protection #ProtectYourHealth

Want to have your comprehensive medical history under your control and at your fingertips? Then join Invitae’s Ciitizen: ciitizen.com/join-us

#MedicalData #Protection #ProtectYourHealth
Invitae (@invitae) 's Twitter Profile Photo

We are excited to join stxbp1 at the 2022 STXBP1 Summit+, August 19-20th! Learn more about our #STXBP1 Natural History Study available now invit.ae/3SKuYvD. #raredisease #epilepsy

We are excited to join <a href="/curestxbp1/">stxbp1</a> at the 2022 STXBP1 Summit+, August 19-20th! Learn more about our #STXBP1 Natural History Study available now invit.ae/3SKuYvD.

#raredisease #epilepsy
Ciitizen (@ciitizen) 's Twitter Profile Photo

Big news! We’re closing this account, but you can still follow us over at Invitae. Thank you to all our dedicated followers and partners. We remain committed to enabling patients more control over their own health records for their personal care coordination needs.

Big news! We’re closing this account, but you can still follow us over at <a href="/Invitae/">Invitae</a>.

Thank you to all our dedicated followers and partners. We remain committed to enabling patients more control over their own health records for their personal care coordination needs.
Ciitizen (@ciitizen) 's Twitter Profile Photo

Thank you to all our dedicated followers and partners! We’re moving all activity over to Invitae. We remain committed to enabling patients more control over their own health records for their personal care coordination needs. Follow us Invitae

Thank you to all our dedicated followers and partners! We’re moving all activity over to <a href="/Invitae/">Invitae</a>. We remain committed to enabling patients more control over their own health records for their personal care coordination needs. Follow us <a href="/Invitae/">Invitae</a>
Ciitizen (@ciitizen) 's Twitter Profile Photo

Last call! Attention to all our dedicated followers and partners. We’re moving all activity over to @invitae. Stay connected with the Inviate Ciitizen community by following us Invitae.

Last call! Attention to all our dedicated followers and partners. We’re moving all activity over to @invitae. Stay connected with the Inviate Ciitizen community by following us <a href="/Invitae/">Invitae</a>.